INS and metabolic syndrome: These findings indicate the beneficial effects of GTP-EGCG against metabolic syndrome and diabetes is not only secondary to inhibiting lipid absorption or antioxidant actions [21] but also through its direct action to enhance glycogen synthesis and decrease lipogenesis in insulin-targeted tissues.